Cardiol Therapeutics Inc. Class A Common Shares (CRDL)
search
Earnings reactions
How CRDL moved on each past earnings report.
Up
Down
Earnings Impact
Cardiol Therapeutics Inc. Class A Common Shares (CRDL) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Cardiol Therapeutics Inc. Class A Common Shares (CRDL) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 6 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
6
Funds holding
$796082
Total value held
Buying
4 added · 1 reduced
Morgan Stanley
$376332
+41.77%
Goldman Sachs Group Inc
$353934
+0.45%
Jpmorgan Chase & Co
$49519
Held
Ubs Group Ag
$8979
NEW BUY
Royal Bank Of Canada
$7000
-68.92%
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 6-K | 20260812 | open_in_new SEC.gov |
| 6-K | 20260805 | open_in_new SEC.gov |
| 6-K | 20260714 | open_in_new SEC.gov |
| 6-K | 20260709 | open_in_new SEC.gov |
| 6-K | 20260625 | open_in_new SEC.gov |
| 6-K | 20260623 | open_in_new SEC.gov |
| 6-K | 20260526 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 6-K | 20260514 | open_in_new SEC.gov |